Leaders in the House and the Senate set aside their competing versions of the Nurse Reinvestment Act and agreed on compromise language to address the national nursing shortage. Lawmakers hope to send the legislation to the president before the August recess. Discussion Draft of Nurse Reinvestment Act Federation of American Hospitals Press Release


PRESCRIPTION DRUGS -- (Senate - July 19, 2002)

[Page: S7099] GPO's PDF


Mrs. LINCOLN. Mr. President, in all the rhetoric and grandstanding about who has the best prescription drug plan, I truly do not want us to forget who we are trying to help.


In an effort to influence members of Congress, brand-name drug companies have poured $423 million over the past three election cycles into campaign contributions and lobbying, a Public Citizen study reveals. Smaller generic drug companies have spent less than two percent of that number, $10 million, and are being overpowered when it comes to currying favor with Congress, Public Citizen says.







Log in to access this content.

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.